id	sid	tid	token	lemma	pos
work_3mfnjd754bbahlbp2z75dzhk7y	1	1	Talking	talk	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	1	2	About	about	IN
work_3mfnjd754bbahlbp2z75dzhk7y	1	3	Harm	Harm	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	4	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	1	5	Benefit	Benefit	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	6	Information	Information	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	7	-	-	,
work_3mfnjd754bbahlbp2z75dzhk7y	1	8	The	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	1	9	Challenges	Challenges	NNPS
work_3mfnjd754bbahlbp2z75dzhk7y	1	10	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	1	11	Healthcare	Healthcare	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	12	Practice	Practice	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	13	This	this	DT
work_3mfnjd754bbahlbp2z75dzhk7y	1	14	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	1	15	a	a	DT
work_3mfnjd754bbahlbp2z75dzhk7y	1	16	repository	repository	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	1	17	copy	copy	NN
work_3mfnjd754bbahlbp2z75dzhk7y	1	18	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	1	19	Talking	talk	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	1	20	About	about	IN
work_3mfnjd754bbahlbp2z75dzhk7y	1	21	Harm	Harm	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	22	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	1	23	Benefit	Benefit	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	24	Information	Information	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	25	-	-	,
work_3mfnjd754bbahlbp2z75dzhk7y	1	26	The	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	1	27	Challenges	Challenges	NNPS
work_3mfnjd754bbahlbp2z75dzhk7y	1	28	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	1	29	Healthcare	Healthcare	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	30	Practice	Practice	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	1	31	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	2	1	White	White	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	2	Rose	Rose	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	3	Research	Research	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	4	Online	Online	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	5	URL	URL	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	6	for	for	IN
work_3mfnjd754bbahlbp2z75dzhk7y	2	7	this	this	DT
work_3mfnjd754bbahlbp2z75dzhk7y	2	8	paper	paper	NN
work_3mfnjd754bbahlbp2z75dzhk7y	2	9	:	:	:
work_3mfnjd754bbahlbp2z75dzhk7y	2	10	http://eprints.whiterose.ac.uk/93946/	http://eprints.whiterose.ac.uk/93946/	ADD
work_3mfnjd754bbahlbp2z75dzhk7y	2	11	Version	version	NN
work_3mfnjd754bbahlbp2z75dzhk7y	2	12	:	:	:
work_3mfnjd754bbahlbp2z75dzhk7y	2	13	Accepted	Accepted	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	14	Version	Version	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	15	Proceedings	Proceedings	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	16	Paper	Paper	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	17	:	:	:
work_3mfnjd754bbahlbp2z75dzhk7y	2	18	Raynor	Raynor	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	19	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	2	20	DK	DK	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	21	(	(	-LRB-
work_3mfnjd754bbahlbp2z75dzhk7y	2	22	2015	2015	CD
work_3mfnjd754bbahlbp2z75dzhk7y	2	23	)	)	-RRB-
work_3mfnjd754bbahlbp2z75dzhk7y	2	24	Talking	talk	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	2	25	About	about	IN
work_3mfnjd754bbahlbp2z75dzhk7y	2	26	Harm	Harm	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	27	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	2	28	Benefit	Benefit	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	29	Information	Information	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	30	-	-	,
work_3mfnjd754bbahlbp2z75dzhk7y	2	31	The	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	2	32	Challenges	Challenges	NNPS
work_3mfnjd754bbahlbp2z75dzhk7y	2	33	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	2	34	Healthcare	Healthcare	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	35	Practice	Practice	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	2	36	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	3	1	In	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	3	2	:	:	:
work_3mfnjd754bbahlbp2z75dzhk7y	3	3	Drug	Drug	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	3	4	Safety	Safety	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	3	5	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	4	1	15th	15th	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	4	2	ISoP	ISoP	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	4	3	Annual	Annual	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	4	4	Meeting	Meeting	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	4	5	“	"	``
work_3mfnjd754bbahlbp2z75dzhk7y	4	6	Cubism	Cubism	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	4	7	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	4	8	Pharmacovigilance	Pharmacovigilance	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	4	9	”	"	''
work_3mfnjd754bbahlbp2z75dzhk7y	4	10	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	4	11	27	27	CD
work_3mfnjd754bbahlbp2z75dzhk7y	4	12	-	-	SYM
work_3mfnjd754bbahlbp2z75dzhk7y	4	13	30	30	CD
work_3mfnjd754bbahlbp2z75dzhk7y	4	14	Oct	Oct	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	4	15	2015	2015	CD
work_3mfnjd754bbahlbp2z75dzhk7y	4	16	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	4	17	Prague	Prague	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	4	18	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	4	19	Czech	Czech	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	4	20	Republic	Republic	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	4	21	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	5	1	Springer	Springer	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	5	2	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	5	3	p.	p.	NN
work_3mfnjd754bbahlbp2z75dzhk7y	5	4	960	960	CD
work_3mfnjd754bbahlbp2z75dzhk7y	5	5	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	5	6	https://doi.org/10.1007/s40264-015-0346-0	https://doi.org/10.1007/s40264-015-0346-0	CD
work_3mfnjd754bbahlbp2z75dzhk7y	5	7	eprints@whiterose.ac.uk	eprints@whiterose.ac.uk	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	5	8	https://eprints.whiterose.ac.uk/	https://eprints.whiterose.ac.uk/	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	5	9	Reuse	reuse	NN
work_3mfnjd754bbahlbp2z75dzhk7y	5	10	Unless	unless	IN
work_3mfnjd754bbahlbp2z75dzhk7y	5	11	indicated	indicate	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	5	12	otherwise	otherwise	RB
work_3mfnjd754bbahlbp2z75dzhk7y	5	13	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	5	14	fulltext	fulltext	NN
work_3mfnjd754bbahlbp2z75dzhk7y	5	15	items	item	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	5	16	are	be	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	5	17	protected	protect	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	5	18	by	by	IN
work_3mfnjd754bbahlbp2z75dzhk7y	5	19	copyright	copyright	NN
work_3mfnjd754bbahlbp2z75dzhk7y	5	20	with	with	IN
work_3mfnjd754bbahlbp2z75dzhk7y	5	21	all	all	DT
work_3mfnjd754bbahlbp2z75dzhk7y	5	22	rights	right	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	5	23	reserved	reserve	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	5	24	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	6	1	The	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	6	2	copyright	copyright	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	3	exception	exception	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	4	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	6	5	section	section	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	6	29	29	CD
work_3mfnjd754bbahlbp2z75dzhk7y	6	7	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	6	8	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	6	9	Copyright	copyright	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	10	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	6	11	Designs	Designs	NNPS
work_3mfnjd754bbahlbp2z75dzhk7y	6	12	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	6	13	Patents	Patents	NNPS
work_3mfnjd754bbahlbp2z75dzhk7y	6	14	Act	Act	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	6	15	1988	1988	CD
work_3mfnjd754bbahlbp2z75dzhk7y	6	16	allows	allow	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	6	17	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	6	18	making	making	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	19	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	6	20	a	a	DT
work_3mfnjd754bbahlbp2z75dzhk7y	6	21	single	single	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	6	22	copy	copy	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	23	solely	solely	RB
work_3mfnjd754bbahlbp2z75dzhk7y	6	24	for	for	IN
work_3mfnjd754bbahlbp2z75dzhk7y	6	25	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	6	26	purpose	purpose	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	27	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	6	28	non	non	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	6	29	-	-	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	6	30	commercial	commercial	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	6	31	research	research	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	32	or	or	CC
work_3mfnjd754bbahlbp2z75dzhk7y	6	33	private	private	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	6	34	study	study	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	35	within	within	IN
work_3mfnjd754bbahlbp2z75dzhk7y	6	36	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	6	37	limits	limit	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	6	38	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	6	39	fair	fair	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	6	40	dealing	dealing	NN
work_3mfnjd754bbahlbp2z75dzhk7y	6	41	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	7	1	The	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	7	2	publisher	publisher	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	3	or	or	CC
work_3mfnjd754bbahlbp2z75dzhk7y	7	4	other	other	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	7	5	rights	right	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	7	6	-	-	HYPH
work_3mfnjd754bbahlbp2z75dzhk7y	7	7	holder	holder	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	8	may	may	MD
work_3mfnjd754bbahlbp2z75dzhk7y	7	9	allow	allow	VB
work_3mfnjd754bbahlbp2z75dzhk7y	7	10	further	further	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	7	11	reproduction	reproduction	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	12	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	7	13	re	re	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	14	-	-	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	15	use	use	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	16	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	7	17	this	this	DT
work_3mfnjd754bbahlbp2z75dzhk7y	7	18	version	version	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	19	-	-	HYPH
work_3mfnjd754bbahlbp2z75dzhk7y	7	20	refer	refer	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	21	to	to	IN
work_3mfnjd754bbahlbp2z75dzhk7y	7	22	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	7	23	White	White	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	7	24	Rose	Rose	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	7	25	Research	Research	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	7	26	Online	Online	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	7	27	record	record	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	28	for	for	IN
work_3mfnjd754bbahlbp2z75dzhk7y	7	29	this	this	DT
work_3mfnjd754bbahlbp2z75dzhk7y	7	30	item	item	NN
work_3mfnjd754bbahlbp2z75dzhk7y	7	31	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	8	1	Where	where	WRB
work_3mfnjd754bbahlbp2z75dzhk7y	8	2	records	record	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	8	3	identify	identify	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	8	4	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	8	5	publisher	publisher	NN
work_3mfnjd754bbahlbp2z75dzhk7y	8	6	as	as	IN
work_3mfnjd754bbahlbp2z75dzhk7y	8	7	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	8	8	copyright	copyright	NN
work_3mfnjd754bbahlbp2z75dzhk7y	8	9	holder	holder	NN
work_3mfnjd754bbahlbp2z75dzhk7y	8	10	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	8	11	users	user	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	8	12	can	can	MD
work_3mfnjd754bbahlbp2z75dzhk7y	8	13	verify	verify	VB
work_3mfnjd754bbahlbp2z75dzhk7y	8	14	any	any	DT
work_3mfnjd754bbahlbp2z75dzhk7y	8	15	specific	specific	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	8	16	terms	term	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	8	17	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	8	18	use	use	NN
work_3mfnjd754bbahlbp2z75dzhk7y	8	19	on	on	IN
work_3mfnjd754bbahlbp2z75dzhk7y	8	20	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	8	21	publisher	publisher	NN
work_3mfnjd754bbahlbp2z75dzhk7y	8	22	’s	’s	POS
work_3mfnjd754bbahlbp2z75dzhk7y	8	23	website	website	NN
work_3mfnjd754bbahlbp2z75dzhk7y	8	24	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	9	1	Takedown	Takedown	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	9	2	If	if	IN
work_3mfnjd754bbahlbp2z75dzhk7y	9	3	you	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	9	4	consider	consider	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	9	5	content	content	NN
work_3mfnjd754bbahlbp2z75dzhk7y	9	6	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	9	7	White	White	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	9	8	Rose	Rose	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	9	9	Research	Research	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	9	10	Online	Online	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	9	11	to	to	TO
work_3mfnjd754bbahlbp2z75dzhk7y	9	12	be	be	VB
work_3mfnjd754bbahlbp2z75dzhk7y	9	13	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	9	14	breach	breach	NN
work_3mfnjd754bbahlbp2z75dzhk7y	9	15	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	9	16	UK	UK	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	9	17	law	law	NN
work_3mfnjd754bbahlbp2z75dzhk7y	9	18	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	9	19	please	please	UH
work_3mfnjd754bbahlbp2z75dzhk7y	9	20	notify	notify	VB
work_3mfnjd754bbahlbp2z75dzhk7y	9	21	us	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	9	22	by	by	IN
work_3mfnjd754bbahlbp2z75dzhk7y	9	23	emailing	email	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	9	24	eprints@whiterose.ac.uk	eprints@whiterose.ac.uk	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	9	25	including	include	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	9	26	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	9	27	URL	url	NN
work_3mfnjd754bbahlbp2z75dzhk7y	9	28	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	9	29	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	9	30	record	record	NN
work_3mfnjd754bbahlbp2z75dzhk7y	9	31	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	9	32	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	9	33	reason	reason	NN
work_3mfnjd754bbahlbp2z75dzhk7y	9	34	for	for	IN
work_3mfnjd754bbahlbp2z75dzhk7y	9	35	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	9	36	withdrawal	withdrawal	NN
work_3mfnjd754bbahlbp2z75dzhk7y	9	37	request	request	NN
work_3mfnjd754bbahlbp2z75dzhk7y	9	38	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	10	1	mailto:eprints@whiterose.ac.uk	mailto:eprints@whiterose.ac.uk	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	2	https://eprints.whiterose.ac.uk/	https://eprints.whiterose.ac.uk/	FW
work_3mfnjd754bbahlbp2z75dzhk7y	10	3	Session	session	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	4	type	type	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	5	Abstract	abstract	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	10	6	submission	submission	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	7	Topic	Topic	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	8	Benefit	Benefit	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	9	/	/	SYM
work_3mfnjd754bbahlbp2z75dzhk7y	10	10	Burden	Burden	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	11	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	10	12	pharmacovigilance	pharmacovigilance	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	13	(	(	-LRB-
work_3mfnjd754bbahlbp2z75dzhk7y	10	14	Pharmacoeconomics	Pharmacoeconomics	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	15	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	10	16	Pharmacovigilance	Pharmacovigilance	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	17	)	)	-RRB-
work_3mfnjd754bbahlbp2z75dzhk7y	10	18	Presentation	Presentation	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	19	preference	preference	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	20	Oral	Oral	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	21	-	-	HYPH
work_3mfnjd754bbahlbp2z75dzhk7y	10	22	invited	invite	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	10	23	Abstract	Abstract	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	10	24	title	title	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	25	Talking	talk	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	10	26	about	about	IN
work_3mfnjd754bbahlbp2z75dzhk7y	10	27	harm	harm	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	28	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	10	29	benefit	benefit	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	30	information	information	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	31	–	–	:
work_3mfnjd754bbahlbp2z75dzhk7y	10	32	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	10	33	challenges	challenge	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	10	34	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	10	35	healthcare	healthcare	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	36	practice	practice	NN
work_3mfnjd754bbahlbp2z75dzhk7y	10	37	Co	Co	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	10	38	-	-	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	10	39	authors	author	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	10	40	D.K.	D.K.	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	11	1	Raynor	Raynor	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	11	2	1,2	1,2	CD
work_3mfnjd754bbahlbp2z75dzhk7y	11	3	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	12	1	1	1	CD
work_3mfnjd754bbahlbp2z75dzhk7y	12	2	University	University	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	3	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	12	4	Leeds	Leeds	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	5	Faculty	Faculty	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	6	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	12	7	Medicine	Medicine	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	8	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	12	9	Health	Health	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	10	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	12	11	School	School	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	12	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	12	13	Healthcare	Healthcare	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	14	-	-	HYPH
work_3mfnjd754bbahlbp2z75dzhk7y	12	15	Pharmacy	Pharmacy	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	16	Practice	Practice	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	17	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	12	18	Leeds	Leeds	NNPS
work_3mfnjd754bbahlbp2z75dzhk7y	12	19	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	12	20	United	United	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	21	Kingdom	Kingdom	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	12	22	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	13	1	2	2	CD
work_3mfnjd754bbahlbp2z75dzhk7y	13	2	Luto	Luto	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	13	3	Research	Research	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	13	4	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	13	5	n	n	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	13	6	/	/	SYM
work_3mfnjd754bbahlbp2z75dzhk7y	13	7	a	a	DT
work_3mfnjd754bbahlbp2z75dzhk7y	13	8	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	13	9	Leeds	Leeds	NNPS
work_3mfnjd754bbahlbp2z75dzhk7y	13	10	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	13	11	United	United	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	13	12	Kingdom	Kingdom	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	13	13	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	14	1	Abstract	abstract	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	14	2	text	text	NN
work_3mfnjd754bbahlbp2z75dzhk7y	14	3	Effective	effective	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	14	4	pharmacovigilance	pharmacovigilance	NN
work_3mfnjd754bbahlbp2z75dzhk7y	14	5	increasingly	increasingly	RB
work_3mfnjd754bbahlbp2z75dzhk7y	14	6	depends	depend	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	14	7	on	on	IN
work_3mfnjd754bbahlbp2z75dzhk7y	14	8	patients	patient	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	14	9	playing	play	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	14	10	their	-PRON-	PRP$
work_3mfnjd754bbahlbp2z75dzhk7y	14	11	part	part	NN
work_3mfnjd754bbahlbp2z75dzhk7y	14	12	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	14	13	but	but	CC
work_3mfnjd754bbahlbp2z75dzhk7y	14	14	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	14	15	‘	'	``
work_3mfnjd754bbahlbp2z75dzhk7y	14	16	dialogue	dialogue	NN
work_3mfnjd754bbahlbp2z75dzhk7y	14	17	’	'	''
work_3mfnjd754bbahlbp2z75dzhk7y	14	18	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	14	19	impeded	impede	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	14	20	because	because	IN
work_3mfnjd754bbahlbp2z75dzhk7y	14	21	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	14	22	patients	patient	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	14	23	’	’	POS
work_3mfnjd754bbahlbp2z75dzhk7y	14	24	lack	lack	NN
work_3mfnjd754bbahlbp2z75dzhk7y	14	25	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	14	26	knowledge	knowledge	NN
work_3mfnjd754bbahlbp2z75dzhk7y	14	27	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	14	28	drug	drug	NN
work_3mfnjd754bbahlbp2z75dzhk7y	14	29	development	development	NN
work_3mfnjd754bbahlbp2z75dzhk7y	14	30	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	14	31	safety	safety	NN
work_3mfnjd754bbahlbp2z75dzhk7y	14	32	measures	measure	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	14	33	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	15	1	However	however	RB
work_3mfnjd754bbahlbp2z75dzhk7y	15	2	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	15	3	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	15	4	main	main	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	15	5	barrier	barrier	NN
work_3mfnjd754bbahlbp2z75dzhk7y	15	6	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	15	7	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	15	8	language	language	NN
work_3mfnjd754bbahlbp2z75dzhk7y	15	9	we	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	15	10	use	use	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	15	11	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	15	12	which	which	WDT
work_3mfnjd754bbahlbp2z75dzhk7y	15	13	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	15	14	not	not	RB
work_3mfnjd754bbahlbp2z75dzhk7y	15	15	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	15	16	language	language	NN
work_3mfnjd754bbahlbp2z75dzhk7y	15	17	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	15	18	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	15	19	man	man	NN
work_3mfnjd754bbahlbp2z75dzhk7y	15	20	or	or	CC
work_3mfnjd754bbahlbp2z75dzhk7y	15	21	woman	woman	NN
work_3mfnjd754bbahlbp2z75dzhk7y	15	22	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	15	23	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	15	24	street	street	NN
work_3mfnjd754bbahlbp2z75dzhk7y	15	25	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	16	1	Even	even	RB
work_3mfnjd754bbahlbp2z75dzhk7y	16	2	many	many	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	16	3	grass	grass	NN
work_3mfnjd754bbahlbp2z75dzhk7y	16	4	roots	root	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	16	5	health	health	NN
work_3mfnjd754bbahlbp2z75dzhk7y	16	6	professionals	professional	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	16	7	struggle	struggle	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	16	8	to	to	TO
work_3mfnjd754bbahlbp2z75dzhk7y	16	9	describe	describe	VB
work_3mfnjd754bbahlbp2z75dzhk7y	16	10	what	what	WP
work_3mfnjd754bbahlbp2z75dzhk7y	16	11	‘	'	``
work_3mfnjd754bbahlbp2z75dzhk7y	16	12	pharmacovigilance	pharmacovigilance	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	16	13	’	'	''
work_3mfnjd754bbahlbp2z75dzhk7y	16	14	means	mean	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	16	15	–	–	:
work_3mfnjd754bbahlbp2z75dzhk7y	16	16	it	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	16	17	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	16	18	meaningless	meaningless	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	16	19	to	to	IN
work_3mfnjd754bbahlbp2z75dzhk7y	16	20	patients	patient	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	16	21	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	17	1	What	what	WDT
work_3mfnjd754bbahlbp2z75dzhk7y	17	2	words	word	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	17	3	would	would	MD
work_3mfnjd754bbahlbp2z75dzhk7y	17	4	they	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	17	5	understand	understand	VB
work_3mfnjd754bbahlbp2z75dzhk7y	17	6	to	to	TO
work_3mfnjd754bbahlbp2z75dzhk7y	17	7	describe	describe	VB
work_3mfnjd754bbahlbp2z75dzhk7y	17	8	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	17	9	process	process	NN
work_3mfnjd754bbahlbp2z75dzhk7y	17	10	?	?	.
work_3mfnjd754bbahlbp2z75dzhk7y	18	1	Equally	equally	RB
work_3mfnjd754bbahlbp2z75dzhk7y	18	2	we	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	18	3	talk	talk	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	18	4	about	about	IN
work_3mfnjd754bbahlbp2z75dzhk7y	18	5	benefit	benefit	NN
work_3mfnjd754bbahlbp2z75dzhk7y	18	6	/	/	SYM
work_3mfnjd754bbahlbp2z75dzhk7y	18	7	risk	risk	NN
work_3mfnjd754bbahlbp2z75dzhk7y	18	8	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	18	9	whereas	whereas	IN
work_3mfnjd754bbahlbp2z75dzhk7y	18	10	what	what	WP
work_3mfnjd754bbahlbp2z75dzhk7y	18	11	we	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	18	12	mean	mean	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	18	13	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	18	14	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	18	15	chance	chance	NN
work_3mfnjd754bbahlbp2z75dzhk7y	18	16	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	18	17	benefit	benefit	NN
work_3mfnjd754bbahlbp2z75dzhk7y	18	18	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	18	19	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	18	20	risk	risk	NN
work_3mfnjd754bbahlbp2z75dzhk7y	18	21	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	18	22	harm	harm	NN
work_3mfnjd754bbahlbp2z75dzhk7y	18	23	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	19	1	Pharmacovigilance	Pharmacovigilance	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	19	2	should	should	MD
work_3mfnjd754bbahlbp2z75dzhk7y	19	3	allow	allow	VB
work_3mfnjd754bbahlbp2z75dzhk7y	19	4	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	19	5	patient	patient	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	6	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	19	7	prescriber	prescriber	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	8	to	to	TO
work_3mfnjd754bbahlbp2z75dzhk7y	19	9	understand	understand	VB
work_3mfnjd754bbahlbp2z75dzhk7y	19	10	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	19	11	benefit	benefit	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	12	/	/	SYM
work_3mfnjd754bbahlbp2z75dzhk7y	19	13	harm	harm	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	14	balance	balance	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	15	for	for	IN
work_3mfnjd754bbahlbp2z75dzhk7y	19	16	a	a	DT
work_3mfnjd754bbahlbp2z75dzhk7y	19	17	medicine	medicine	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	18	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	19	19	decide	decide	VB
work_3mfnjd754bbahlbp2z75dzhk7y	19	20	if	if	IN
work_3mfnjd754bbahlbp2z75dzhk7y	19	21	it	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	19	22	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	19	23	right	right	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	19	24	for	for	IN
work_3mfnjd754bbahlbp2z75dzhk7y	19	25	them	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	19	26	–	–	:
work_3mfnjd754bbahlbp2z75dzhk7y	19	27	but	but	CC
work_3mfnjd754bbahlbp2z75dzhk7y	19	28	we	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	19	29	currently	currently	RB
work_3mfnjd754bbahlbp2z75dzhk7y	19	30	only	only	RB
work_3mfnjd754bbahlbp2z75dzhk7y	19	31	given	give	VBD
work_3mfnjd754bbahlbp2z75dzhk7y	19	32	them	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	19	33	numerical	numerical	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	19	34	information	information	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	35	about	about	IN
work_3mfnjd754bbahlbp2z75dzhk7y	19	36	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	19	37	risk	risk	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	38	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	19	39	harm	harm	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	40	(	(	-LRB-
work_3mfnjd754bbahlbp2z75dzhk7y	19	41	‘	'	``
work_3mfnjd754bbahlbp2z75dzhk7y	19	42	affects	affect	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	19	43	less	less	JJR
work_3mfnjd754bbahlbp2z75dzhk7y	19	44	than	than	IN
work_3mfnjd754bbahlbp2z75dzhk7y	19	45	1	1	CD
work_3mfnjd754bbahlbp2z75dzhk7y	19	46	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	19	47	10	10	CD
work_3mfnjd754bbahlbp2z75dzhk7y	19	48	people	people	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	19	49	’	'	''
work_3mfnjd754bbahlbp2z75dzhk7y	19	50	)	)	-RRB-
work_3mfnjd754bbahlbp2z75dzhk7y	19	51	–	–	:
work_3mfnjd754bbahlbp2z75dzhk7y	19	52	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	19	53	nothing	nothing	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	54	about	about	IN
work_3mfnjd754bbahlbp2z75dzhk7y	19	55	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	19	56	chance	chance	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	57	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	19	58	benefit	benefit	NN
work_3mfnjd754bbahlbp2z75dzhk7y	19	59	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	20	1	This	this	DT
work_3mfnjd754bbahlbp2z75dzhk7y	20	2	means	mean	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	20	3	a	a	DT
work_3mfnjd754bbahlbp2z75dzhk7y	20	4	truly	truly	RB
work_3mfnjd754bbahlbp2z75dzhk7y	20	5	informed	inform	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	20	6	decision	decision	NN
work_3mfnjd754bbahlbp2z75dzhk7y	20	7	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	20	8	not	not	RB
work_3mfnjd754bbahlbp2z75dzhk7y	20	9	possible	possible	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	20	10	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	21	1	So	so	CC
work_3mfnjd754bbahlbp2z75dzhk7y	21	2	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	21	3	how	how	WRB
work_3mfnjd754bbahlbp2z75dzhk7y	21	4	can	can	MD
work_3mfnjd754bbahlbp2z75dzhk7y	21	5	we	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	21	6	best	good	JJS
work_3mfnjd754bbahlbp2z75dzhk7y	21	7	describe	describe	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	21	8	numerically	numerically	RB
work_3mfnjd754bbahlbp2z75dzhk7y	21	9	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	21	10	chance	chance	NN
work_3mfnjd754bbahlbp2z75dzhk7y	21	11	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	21	12	benefit	benefit	NN
work_3mfnjd754bbahlbp2z75dzhk7y	21	13	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	21	14	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	21	15	where	where	WRB
work_3mfnjd754bbahlbp2z75dzhk7y	21	16	can	can	MD
work_3mfnjd754bbahlbp2z75dzhk7y	21	17	we	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	21	18	source	source	VB
work_3mfnjd754bbahlbp2z75dzhk7y	21	19	that	that	DT
work_3mfnjd754bbahlbp2z75dzhk7y	21	20	information	information	NN
work_3mfnjd754bbahlbp2z75dzhk7y	21	21	?	?	.
work_3mfnjd754bbahlbp2z75dzhk7y	22	1	User	user	NN
work_3mfnjd754bbahlbp2z75dzhk7y	22	2	testing	testing	NN
work_3mfnjd754bbahlbp2z75dzhk7y	22	3	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	22	4	patient	patient	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	22	5	information	information	NN
work_3mfnjd754bbahlbp2z75dzhk7y	22	6	leaflets	leaflet	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	22	7	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	22	8	helping	help	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	22	9	to	to	TO
work_3mfnjd754bbahlbp2z75dzhk7y	22	10	make	make	VB
work_3mfnjd754bbahlbp2z75dzhk7y	22	11	such	such	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	22	12	leaflets	leaflet	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	22	13	fit	fit	VB
work_3mfnjd754bbahlbp2z75dzhk7y	22	14	-	-	HYPH
work_3mfnjd754bbahlbp2z75dzhk7y	22	15	for-	for-	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	22	16	purpose	purpose	NN
work_3mfnjd754bbahlbp2z75dzhk7y	22	17	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	22	18	but	but	CC
work_3mfnjd754bbahlbp2z75dzhk7y	22	19	wordings	wording	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	22	20	imposed	impose	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	22	21	by	by	IN
work_3mfnjd754bbahlbp2z75dzhk7y	22	22	regulators	regulator	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	22	23	are	be	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	22	24	not	not	RB
work_3mfnjd754bbahlbp2z75dzhk7y	22	25	tested	test	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	22	26	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	23	1	The	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	23	2	wording	wording	NN
work_3mfnjd754bbahlbp2z75dzhk7y	23	3	associated	associate	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	23	4	with	with	IN
work_3mfnjd754bbahlbp2z75dzhk7y	23	5	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	23	6	Black	Black	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	23	7	Triangle	Triangle	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	23	8	initiative	initiative	NN
work_3mfnjd754bbahlbp2z75dzhk7y	23	9	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	23	10	a	a	DT
work_3mfnjd754bbahlbp2z75dzhk7y	23	11	case	case	NN
work_3mfnjd754bbahlbp2z75dzhk7y	23	12	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	23	13	point	point	NN
work_3mfnjd754bbahlbp2z75dzhk7y	23	14	:	:	:
work_3mfnjd754bbahlbp2z75dzhk7y	23	15	‘	'	``
work_3mfnjd754bbahlbp2z75dzhk7y	23	16	Warning	warning	NN
work_3mfnjd754bbahlbp2z75dzhk7y	23	17	–	–	:
work_3mfnjd754bbahlbp2z75dzhk7y	23	18	this	this	DT
work_3mfnjd754bbahlbp2z75dzhk7y	23	19	medicine	medicine	NN
work_3mfnjd754bbahlbp2z75dzhk7y	23	20	is	be	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	23	21	subject	subject	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	23	22	to	to	IN
work_3mfnjd754bbahlbp2z75dzhk7y	23	23	additional	additional	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	23	24	monitoring	monitoring	NN
work_3mfnjd754bbahlbp2z75dzhk7y	23	25	’	'	''
work_3mfnjd754bbahlbp2z75dzhk7y	23	26	means	mean	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	23	27	something	something	NN
work_3mfnjd754bbahlbp2z75dzhk7y	23	28	quite	quite	RB
work_3mfnjd754bbahlbp2z75dzhk7y	23	29	different	different	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	23	30	to	to	IN
work_3mfnjd754bbahlbp2z75dzhk7y	23	31	some	some	DT
work_3mfnjd754bbahlbp2z75dzhk7y	23	32	lay	lay	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	23	33	people	people	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	23	34	–	–	:
work_3mfnjd754bbahlbp2z75dzhk7y	23	35	they	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	23	36	think	think	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	23	37	it	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	23	38	means	mean	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	23	39	that	that	IN
work_3mfnjd754bbahlbp2z75dzhk7y	23	40	they	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	23	41	will	will	MD
work_3mfnjd754bbahlbp2z75dzhk7y	23	42	have	have	VB
work_3mfnjd754bbahlbp2z75dzhk7y	23	43	more	more	JJR
work_3mfnjd754bbahlbp2z75dzhk7y	23	44	tests	test	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	23	45	or	or	CC
work_3mfnjd754bbahlbp2z75dzhk7y	23	46	checks	check	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	23	47	(	(	-LRB-
work_3mfnjd754bbahlbp2z75dzhk7y	23	48	monitoring	monitor	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	23	49	)	)	-RRB-
work_3mfnjd754bbahlbp2z75dzhk7y	23	50	if	if	IN
work_3mfnjd754bbahlbp2z75dzhk7y	23	51	they	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	23	52	take	take	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	23	53	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	23	54	medicine	medicine	NN
work_3mfnjd754bbahlbp2z75dzhk7y	23	55	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	24	1	Equally	equally	RB
work_3mfnjd754bbahlbp2z75dzhk7y	24	2	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	24	3	wordings	wording	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	24	4	recommended	recommend	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	24	5	by	by	IN
work_3mfnjd754bbahlbp2z75dzhk7y	24	6	PRAC	PRAC	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	24	7	appear	appear	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	24	8	less	less	JJR
work_3mfnjd754bbahlbp2z75dzhk7y	24	9	than	than	IN
work_3mfnjd754bbahlbp2z75dzhk7y	24	10	ideal	ideal	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	24	11	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	24	12	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	24	13	are	be	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	24	14	un	un	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	24	15	-	-	HYPH
work_3mfnjd754bbahlbp2z75dzhk7y	24	16	tested	test	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	24	17	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	25	1	Finally	finally	RB
work_3mfnjd754bbahlbp2z75dzhk7y	25	2	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	25	3	Risk	Risk	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	25	4	Management	Management	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	25	5	Plan	Plan	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	25	6	summaries	summary	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	25	7	are	be	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	25	8	designed	design	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	25	9	to	to	TO
work_3mfnjd754bbahlbp2z75dzhk7y	25	10	inform	inform	VB
work_3mfnjd754bbahlbp2z75dzhk7y	25	11	lay	lay	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	25	12	people	people	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	25	13	about	about	IN
work_3mfnjd754bbahlbp2z75dzhk7y	25	14	how	how	WRB
work_3mfnjd754bbahlbp2z75dzhk7y	25	15	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	25	16	plans	plan	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	25	17	for	for	IN
work_3mfnjd754bbahlbp2z75dzhk7y	25	18	safe	safe	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	25	19	use	use	NN
work_3mfnjd754bbahlbp2z75dzhk7y	25	20	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	25	21	medicines	medicine	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	25	22	have	have	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	25	23	been	be	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	25	24	developed	develop	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	25	25	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	25	26	put	put	VBN
work_3mfnjd754bbahlbp2z75dzhk7y	25	27	into	into	IN
work_3mfnjd754bbahlbp2z75dzhk7y	25	28	practice	practice	NN
work_3mfnjd754bbahlbp2z75dzhk7y	25	29	.	.	.
work_3mfnjd754bbahlbp2z75dzhk7y	26	1	But	but	CC
work_3mfnjd754bbahlbp2z75dzhk7y	26	2	what	what	WP
work_3mfnjd754bbahlbp2z75dzhk7y	26	3	does	do	VBZ
work_3mfnjd754bbahlbp2z75dzhk7y	26	4	user	user	VB
work_3mfnjd754bbahlbp2z75dzhk7y	26	5	testing	testing	NN
work_3mfnjd754bbahlbp2z75dzhk7y	26	6	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	26	7	RMP	RMP	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	26	8	Summaries	Summaries	NNPS
work_3mfnjd754bbahlbp2z75dzhk7y	26	9	show	show	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	26	10	?	?	.
work_3mfnjd754bbahlbp2z75dzhk7y	27	1	Are	be	VBP
work_3mfnjd754bbahlbp2z75dzhk7y	27	2	they	-PRON-	PRP
work_3mfnjd754bbahlbp2z75dzhk7y	27	3	fit	fit	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	27	4	for	for	IN
work_3mfnjd754bbahlbp2z75dzhk7y	27	5	purpose	purpose	NN
work_3mfnjd754bbahlbp2z75dzhk7y	27	6	?	?	.
work_3mfnjd754bbahlbp2z75dzhk7y	28	1	This	this	DT
work_3mfnjd754bbahlbp2z75dzhk7y	28	2	presentation	presentation	NN
work_3mfnjd754bbahlbp2z75dzhk7y	28	3	will	will	MD
work_3mfnjd754bbahlbp2z75dzhk7y	28	4	draw	draw	VB
work_3mfnjd754bbahlbp2z75dzhk7y	28	5	on	on	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	6	academic	academic	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	28	7	research	research	NN
work_3mfnjd754bbahlbp2z75dzhk7y	28	8	from	from	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	9	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	28	10	University	University	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	28	11	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	12	Leeds	Leeds	NNPS
work_3mfnjd754bbahlbp2z75dzhk7y	28	13	on	on	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	14	describing	describe	VBG
work_3mfnjd754bbahlbp2z75dzhk7y	28	15	benefit	benefit	NN
work_3mfnjd754bbahlbp2z75dzhk7y	28	16	and	and	CC
work_3mfnjd754bbahlbp2z75dzhk7y	28	17	harm	harm	VB
work_3mfnjd754bbahlbp2z75dzhk7y	28	18	information	information	NN
work_3mfnjd754bbahlbp2z75dzhk7y	28	19	for	for	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	20	patients	patient	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	28	21	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	28	22	along	along	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	23	with	with	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	24	practical	practical	JJ
work_3mfnjd754bbahlbp2z75dzhk7y	28	25	examples	example	NNS
work_3mfnjd754bbahlbp2z75dzhk7y	28	26	from	from	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	27	user	user	NN
work_3mfnjd754bbahlbp2z75dzhk7y	28	28	testing	testing	NN
work_3mfnjd754bbahlbp2z75dzhk7y	28	29	in	in	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	30	practice	practice	NN
work_3mfnjd754bbahlbp2z75dzhk7y	28	31	by	by	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	32	Luto	Luto	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	28	33	Research	Research	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	28	34	,	,	,
work_3mfnjd754bbahlbp2z75dzhk7y	28	35	a	a	DT
work_3mfnjd754bbahlbp2z75dzhk7y	28	36	spin	spin	NN
work_3mfnjd754bbahlbp2z75dzhk7y	28	37	out	out	RP
work_3mfnjd754bbahlbp2z75dzhk7y	28	38	company	company	NN
work_3mfnjd754bbahlbp2z75dzhk7y	28	39	of	of	IN
work_3mfnjd754bbahlbp2z75dzhk7y	28	40	the	the	DT
work_3mfnjd754bbahlbp2z75dzhk7y	28	41	University	University	NNP
work_3mfnjd754bbahlbp2z75dzhk7y	28	42	.	.	.